You are here

  • Home
  • Archive
  • Volume 23, Issue Suppl 1
  • CP-207 Analysis of effectiveness and safety of enzalutamide and abiraterone in patients with unresectable prostate adenocarcinoma resistant to castration

Article metrics

Article menu
Download PDFPDF
Clinical pharmacy
CP-207 Analysis of effectiveness and safety of enzalutamide and abiraterone in patients with unresectable prostate adenocarcinoma resistant to castration

 

Online download statistics by month:

Online download statistics by month: March 2016 to March 2024

AbstractFullPdf
Mar 2016100
Apr 2016503
Jun 20161100
Jul 2016602
Aug 2016100
Sep 2016100
Oct 2016300
Nov 2016900
Dec 2016400
Jan 2017600
Feb 2017902
Mar 20171003
Apr 2017200
May 20171000
Jun 20171300
Jul 2017200
Aug 20173600
Sep 20171600
Oct 20171600
Nov 20172000
Dec 20171400
Jan 20184200
Feb 20183800
Mar 20183600
Apr 20182201
May 20189200
Jun 20181400
Jul 20181000
Aug 2018800
Sep 20182200
Oct 20181601
Nov 20181400
Dec 20185000
Jan 20196901
Feb 2019900
Mar 2019200
Apr 2019401
May 2019400
Jun 2019200
Jul 2019400
Aug 2019200
Sep 2019400
Oct 20191400
Nov 2019400
Dec 2019800
Jan 20201000
Feb 20201400
Mar 20202300
Apr 2020200
May 2020600
Jun 20201400
Jul 2020600
Aug 2020400
Sep 20201501
Oct 20204500
Nov 20203600
Dec 2020400
Jan 2021500
Feb 2021700
Mar 20211800
Apr 20211200
Jul 2021100
Oct 2021600
Nov 20211200
Dec 2021200
Jan 20221200
Feb 2022402
Mar 20223400
Apr 20221500
May 2022400
Jun 20221102
Jul 20221000
Aug 2022600
Sep 2022400
Oct 2022200
Nov 20221600
Dec 2022600
Jan 2023200
Feb 2023400
Mar 20231000
Apr 20232600
May 2023800
Jun 2023200
Jul 20232600
Aug 2023400
Sep 2023600
Nov 2023400
Dec 2023400
Jan 2024200
Feb 2024601
Mar 20241200
Total1167020